Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Zarrabi

Showing results (251-260 of 302) with videos related to

Pageof 31
Sort By:
International Journal of Biological Macromolecules|February 24, 2022
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 7, 2022
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approachesMilad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2021
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilitiesMilad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Cellular Signalling|March 31, 2022
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventionsMahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translationSepideh Mirzaei, Mohammad Hossein Gholami, Mahmood Khaksary Mahabady, et al.
International Journal of Biological Macromolecules|September 25, 2021
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidenceMahshid Deldar Abad Paskeh, Sepideh Mirzaei, Sima Orouei, et al.
Advanced Healthcare Materials|March 31, 2026
Bioactive Copper-Doped Natural Hydroxyapatite Quantum Dots/Graphene Oxide Nanocomposites in 3D-Printed PCL Scaffolds for Superior Osteogenic and Angiogenic Performance in Bone Tissue EngineeringHossein Maleki-Ghaleh, Jan Paczesny, Fatemeh Shahriyari, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 15, 2021
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospectsMahshid Deldar Abad Paskeh, Atefeh Mehrabi, Mohammad Hossein Gholami, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 2022
Customizing nano-chitosan for sustainable drug deliveryMostafa Saeedi, Omid Vahidi, Mohammad Reza Moghbeli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2022
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodelingMaliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Pageof 31

Showing results (251-260 of 302) with videos related to

Sort By:
Pageof 31
International Journal of Biological Macromolecules|February 24, 2022
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 7, 2022
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approachesMilad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2021
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilitiesMilad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Cellular Signalling|March 31, 2022
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventionsMahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 31, 2020
Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translationSepideh Mirzaei, Mohammad Hossein Gholami, Mahmood Khaksary Mahabady, et al.
International Journal of Biological Macromolecules|September 25, 2021
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidenceMahshid Deldar Abad Paskeh, Sepideh Mirzaei, Sima Orouei, et al.
Advanced Healthcare Materials|March 31, 2026
Bioactive Copper-Doped Natural Hydroxyapatite Quantum Dots/Graphene Oxide Nanocomposites in 3D-Printed PCL Scaffolds for Superior Osteogenic and Angiogenic Performance in Bone Tissue EngineeringHossein Maleki-Ghaleh, Jan Paczesny, Fatemeh Shahriyari, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 15, 2021
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospectsMahshid Deldar Abad Paskeh, Atefeh Mehrabi, Mohammad Hossein Gholami, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 2022
Customizing nano-chitosan for sustainable drug deliveryMostafa Saeedi, Omid Vahidi, Mohammad Reza Moghbeli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2022
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodelingMaliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Pageof 31